Our Expertise ranges from Pharmaceuticals Formulation, Pharmaceutical Sterilization, Pharmaceuticals Depyrogenation.
Pharmaceutical Capping and Codding, Pharmaceuticals Filling and Pharmaceutical Inspection.
At Kenneth Pharmaceuticals we would use advanced manufacturing Technology for specialized Medicine and Therapeutics Production.
At Kenneth Pharmaceuticals, Our portfolio includes versatile Overseal capping systems for vials and infusion bottles, allowing precise adjustment to accommodate various stopper and cap combinations.
Engineered for accuracy and care, our systems incorporate gentle and controlled transport mechanisms that protect product quality throughout the process.
Kenneth Pharmaceuticals offers a comprehensive portfolio of compact pharmaceutical cleaning systems designed to meet low, medium, and high production output demands. Before vials, ampoules, syringes, and cartridges can be safely filled and sealed, they must undergo a critical preparatory step: thorough external cleaning.
Kenneth Pharmaceuticals provides modular solutions for both small- and large-volume parenteral (SVP and LVP) manufacturing, supporting batch sizes from 13 to 20,000 liters. These systems are designed for GMP-compliant production of SVPs, LVPs, intravenous (IV) infusion products, as well as buffer and media preparations.
At Kenneth Pharmaceuticals Our Clinical Phases has specific Purpose:
Phase I: Safety and dosage in a small group of healthy volunteers or patients.
Phase II: Effectiveness and side Effect profile in a larger patients group.
Phase III: large-scale Testing to confirm efficacy, monitor side effects, and compare to standard treatments.
Phase IV: Post-marketing surveillance to track long-term effects and rare side Effects.
At Kenneth Pharmaceuticals, our scientific expertise focus on attracting the right partners:
We are focusing on development of new medicines vaccines and
therapeutics modalities in area ranging from drug discovery and
development, Oncology, Neurology ,rare disease immunology and
Small molecules, Biologics and gene therapy development.
Kenneth Pharmaceuticals operates in strict alignment with the United States Food and Drug Administration (FDA) comprehensive, lifecycle-based oversight framework. From initial laboratory discovery through commercial distribution, our processes are designed to meet or exceed federal benchmarks for safety, purity, and efficacy.
Rigorous Pre-Approval Validation: Every therapeutic candidate and innovative product under a New Drug Application (NDA) or a generic equivalent under an Abbreviated New Drug Application (ANDA) would undergoes exhaustive testing to establish rigid target specifications. We welcome and fully cooperate with the FDA’s Pre-Approval Inspections (PAIs) to verify our facilities' readiness before any product is brought to market.
Adherence to Current Good Manufacturing Practices (CGMP): Our manufacturing facilities, would strictly operate under CGMP regulations. We invest continuously in process validation, strict material component controls, and cutting-edge laboratory testing equipment.
Independent Quality Authority: Our internal Quality Control and Assurance units operate with total autonomy. They possess the sole legal and organizational authority to accept or reject raw materials, packaging, and finished products, ensuring that commercial interests never compromise patient safety.
Continuous Post-Market Vigilance: Our responsibility to the patient does not end at shipment. Kenneth Pharmaceuticals maintains robust post-market surveillance systems to monitor real-world product performance, manage ongoing stability testing, and report adverse events transparently to federal databases.